[go: up one dir, main page]

WO2010045617A9 - Détection d'anomalies génétiques - Google Patents

Détection d'anomalies génétiques Download PDF

Info

Publication number
WO2010045617A9
WO2010045617A9 PCT/US2009/061096 US2009061096W WO2010045617A9 WO 2010045617 A9 WO2010045617 A9 WO 2010045617A9 US 2009061096 W US2009061096 W US 2009061096W WO 2010045617 A9 WO2010045617 A9 WO 2010045617A9
Authority
WO
WIPO (PCT)
Prior art keywords
genetic abnormalities
detecting genetic
compositions
present
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/061096
Other languages
English (en)
Other versions
WO2010045617A2 (fr
Inventor
Aoy Tomita Mitchell
Michael Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Louisville Research Foundation ULRF
Original Assignee
University of Louisville Research Foundation ULRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Louisville Research Foundation ULRF filed Critical University of Louisville Research Foundation ULRF
Publication of WO2010045617A2 publication Critical patent/WO2010045617A2/fr
Publication of WO2010045617A9 publication Critical patent/WO2010045617A9/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PCT/US2009/061096 2008-10-17 2009-10-16 Détection d'anomalies génétiques Ceased WO2010045617A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10643508P 2008-10-17 2008-10-17
US61/106,435 2008-10-17

Publications (2)

Publication Number Publication Date
WO2010045617A2 WO2010045617A2 (fr) 2010-04-22
WO2010045617A9 true WO2010045617A9 (fr) 2010-08-26

Family

ID=42107299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/061096 Ceased WO2010045617A2 (fr) 2008-10-17 2009-10-16 Détection d'anomalies génétiques

Country Status (1)

Country Link
WO (1) WO2010045617A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US8825412B2 (en) 2010-05-18 2014-09-02 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
RU2671980C2 (ru) 2011-02-09 2018-11-08 Натера, Инк. Способы неинвазивного пренатального установления плоидности
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
JP6659575B2 (ja) 2014-04-21 2020-03-04 ナテラ， インコーポレイテッド 変異の検出および染色体分節の倍数性
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP4428863A3 (fr) 2015-05-11 2024-12-11 Natera, Inc. Procédés et compositions pour déterminer la ploïdie
WO2017181202A2 (fr) 2016-04-15 2017-10-19 Natera, Inc. Procédés de détection du cancer du poumon
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CA3085933A1 (fr) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Evaluation de la compatibilite d'une greffe pour la transplantation
AU2019251504B2 (en) 2018-04-14 2025-09-25 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor DNA
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3980559A1 (fr) 2019-06-06 2022-04-13 Natera, Inc. Procédés de détection d'adn de cellules immunitaires et de surveillance du système immunitaire

Also Published As

Publication number Publication date
WO2010045617A2 (fr) 2010-04-22

Similar Documents

Publication Publication Date Title
WO2010045617A9 (fr) Détection d'anomalies génétiques
WO2012019198A3 (fr) Systèmes de dosage pour analyse génétique
EP4450645A3 (fr) Procédés de détermination de fraction d'acides nucléiques foetaux dans d'échantillons maternels
WO2011142836A3 (fr) Analyses pour la détection d'un génotype, de mutations, et/ou d'une aneuploïdie
WO2010033639A9 (fr) Procédés et compositions pour enrichissement basé sur la méthylation en acide nucléique foetal dans un échantillon maternel, utiles pour les diagnostics prénatals non invasifs
WO2011053790A3 (fr) Dosage de cibles étroitement liées en diagnostic foetal et dosage de détection de coïncidence pour l'analyse génétique
WO2009092035A3 (fr) Procédés et compositions pour l'analyse de molécules biologiques
WO2009015863A3 (fr) Procédés d'identification faisant appel à la méthylation de cpg
WO2009048530A3 (fr) Dosages à base de particules hautement multiplexées
EP4289969A3 (fr) Nouveau marqueur f tal de méthylation
EP2121986A4 (fr) Compositions et procédés de détection d'acide nucléique par le biais d'une réaction de clivage
WO2009114543A3 (fr) Tests adn pour déterminer le sexe d'un bébé avant sa naissance
NZ601079A (en) Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
WO2010065470A3 (fr) Compositions et méthodes pour détecter un adn masculin pendant la détermination du sexe foetal
WO2008024473A3 (fr) Cartographie d'interactions génomiques
WO2009049916A3 (fr) Procédé de détermination de la présence d'une méthylation des résidus cytosine
NZ582702A (en) Diagnosing fetal chromosomal aneuploidy using genomic sequencing
EP2094867A4 (fr) Procédés et compositions pour la détection d'un acide nucléique par une réaction de clivage
TW200700558A (en) A method for the detection of chromosomal aneuploidies
WO2012129363A3 (fr) Détection et analyse d'acide nucléique d'une cellule isolée
EP2227562A4 (fr) Dosage pour détecter des anomalies génétiques dans des acides nucléiques génomiques
WO2012088348A3 (fr) Détection de variations génétiques fœtales
EP3955004A3 (fr) Utilisation d'acides gras dans des procedes de detection de cancer
WO2009124255A8 (fr) Procédés pour l'analyse de produit de transcription
WO2013132074A3 (fr) Test de génotypage pour évaluer le risque d'autisme

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09821366

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 09821366

Country of ref document: EP

Kind code of ref document: A2